Kirby Institute

young person with a PrEP pill

For World AIDS Day, Curtis Chan from the Kirby Institute talks through the findings of the PrEP Appeal Study. The research found that cost and access are the main barriers to more people using pre-exposure prophylaxis, or PrEP.

person wearing a red ribbon

Australia is getting close to eliminating HIV transmission, but inequities in the delivery and uptake of prevention and treatment strategies remain.

EPICC partners launch event

The Kirby Institute at UNSW Sydney is part of a consortium to receive funding and will lead program implementation in the Indo-Pacific.

Woman wearing face mask

This is expected to be the smallest Omicron wave so far. But eligible older and vulnerable people are still recommended to have a booster.

Scientia Professor Rebecca Ivers, Professor Stuart Tangye and Professor Gail Matthews

Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.

Epiwatch team

The Kirby Institute has developed the first non-English version of its AI-driven epidemic warning tool EPIWATCH, expanding its availability in one of the world's most populous countries.

Artist's impression of coronavirus

The World Health Organization has classified the EG.5 family of Omicron variants, including Eris, as ‘variants of interest’. What does that mean? And how does Eris differ to other Omicron variants?

The siRNA recruits proteins and slices up the virus

If proven effective in future clinical trials, these therapeutics will be a key tool in the fight against COVID-19.

NHMRC Funding

Project goals include improving long-term health for people living with HIV, fighting kidney disease and lessening the negative effects of chemotherapy in cancer patients.

Eureka Prize 2023

UNSW researchers have been named as finalists in Australia’s most high-profile science awards.

Pages